Asymmetric dimethylarginine: An crucial regulator in tissue fibrosis

Fibrosis is a reparative process with very few therapeutic options to prevent its progression to organ dysfunction. Chronic fibrotic diseases contribute to an estimated 45% of all death in the industrialized world. Asymmetric dimethylarginine (ADMA), an endothelial nitric oxide synthase inhibitor, p...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of pharmacology 2019-07, Vol.854, p.54-61
Hauptverfasser:	Zhao, Wei-Chen, Li, Ge, Huang, Chu-Yi, Jiang, Jun-Lin
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Arginine - analogs & derivatives Arginine - metabolism Asymmetric dimethylarginine Dimethylarginine dimethylaminohydrolase Fibrosis - metabolism Humans Tissue fibrosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!